SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-011360
Filing Date
2022-03-22
Accepted
2022-03-22 16:06:11
Documents
13
Period of Report
2022-03-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hsto-8k_20220318.htm   iXBRL 8-K 40993
2 EX-10.1 hsto-ex101_6.htm EX-10.1 15315
  Complete submission text file 0001564590-22-011360.txt   188832

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA hsto-20220318.xsd EX-101.SCH 5705
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE hsto-20220318_lab.xml EX-101.LAB 19431
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hsto-20220318_pre.xml EX-101.PRE 11591
7 EXTRACTED XBRL INSTANCE DOCUMENT hsto-8k_20220318_htm.xml XML 3549
Mailing Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121
Business Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121 (858) 526-3100
Histogen Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36003 | Film No.: 22759560
SIC: 2834 Pharmaceutical Preparations